Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
J Biol Chem. 2012 Oct 19;287(43):36022-8. doi: 10.1074/jbc.M112.375873. Epub 2012 Aug 30.
Bifunctional chondroitin synthase K4CP catalyzes glucuronic acid and N-acetylgalactosamine transfer activities and polymerizes a chondroitin chain. Here we have determined that an N-terminal region (residues 58-134) coordinates two transfer reactions and enables K4CP to catalyze polymerization. When residues 58-107 are deleted, K4CP loses polymerase activity while retaining both transfer activities. Peptide (113)DWPSDL(118) within this N-terminal region interacts with C-terminal peptide (677)YTWEKI(682). The deletion of either sequence abolishes glucuronic acid but not N-acetylgalactosamine transfer activity in K4CP. Both donor bindings and transfer activities are lost by mutating (677)YTWEKI(682) to (677)DAWEDI(682). On the other hand, acceptor substrates retain their binding to K4CP mutants. The characteristics of these K4CP mutants highlight different states of the enzyme reaction, providing an underlying structural basis for how these peptides play essential roles in coordinating the two glycosyltransferase activities for K4CP to elongate the chondroitin chain.
双功能硫酸软骨素合成酶 K4CP 催化葡萄糖醛酸和 N-乙酰半乳糖胺转移活性,并聚合硫酸软骨素链。在这里,我们已经确定,N 端区域(残基 58-134)协调两个转移反应,并使 K4CP 能够催化聚合反应。当删除 58-107 个残基时,K4CP 失去聚合酶活性,同时保留两种转移活性。此 N 端区域内的肽(113)DWPSDL(118)与 C 端肽(677)YTWEKI(682)相互作用。删除任一序列都会使 K4CP 中的葡萄糖醛酸但不 N-乙酰半乳糖胺转移活性丧失。突变(677)YTWEKI(682)为(677)DAWEDI(682)会导致供体结合和转移活性均丧失。另一方面,受体底物保留与其 K4CP 突变体的结合。这些 K4CP 突变体的特征突出了酶反应的不同状态,为这些肽如何在协调 K4CP 的两种糖基转移酶活性以延长硫酸软骨素链中发挥重要作用提供了潜在的结构基础。